title: Is the use of artificial hearts the future solution for interim treatment of patients awaiting retransplantation?
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Hopital de la Pitie, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Cabrol
authors.forename: I
authors.initials: I
authors.lastname: Gandjbakhch
authors.forename: A
authors.initials: A
authors.lastname: Pavie
authors.forename: V
authors.initials: V
authors.lastname: Bors
authors.forename: A
authors.initials: A
authors.lastname: Cabrol
authors.forename: P
authors.initials: P
authors.lastname: Leger
authors.forename: E
authors.initials: E
authors.lastname: Vaissier
authors.forename: J P
authors.initials: JP
authors.lastname: Levasseur
authors.forename: J
authors.initials: J
authors.lastname: Petrie
authors.forename: J C
authors.initials: JC
authors.lastname: Simoneau
mesh_terms: D000293:Adolescent; D000328:Adult; D003324:Coronary Artery Disease / Q000209:etiology; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation; D006354:Heart, Artificial; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012086:Reoperation; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000009:adverse effects